The device maker recalled the Rejuvenate and ABG II hip implants in 2012 after higher than normal failure and revision surgery rates. Prior to the recall, Stryker sent an Urgent Field Safety Notice to doctors informing them that the stems could allow metal debris into the blood and nearby tissues.